相似文献
1
Why ethics guidance needs to be updated for contemporary HIV prevention research.
J Int AIDS Soc. 2020 May;23(5):e25500. doi: 10.1002/jia2.25500.
2
HIV prevention research and COVID-19: putting ethics guidance to the test.
BMC Med Ethics. 2021 Jan 25;22(1):6. doi: 10.1186/s12910-021-00575-w.
3
Strengthening stakeholder engagement through ethics review in biomedical HIV prevention trials: opportunities and complexities.
J Int AIDS Soc. 2018 Oct;21 Suppl 7(Suppl Suppl 7):e25172. doi: 10.1002/jia2.25172.
4
Developing ethics guidance for HIV prevention research: the HIV Prevention Trials Network approach.
J Med Ethics. 2010 Dec;36(12):810-5. doi: 10.1136/jme.2010.035444.
5
Standard of care for social harms in HIV prevention trials: A South African perspective.
Dev World Bioeth. 2020 Dec;20(4):194-199. doi: 10.1111/dewb.12255. Epub 2019 Dec 13.
6
South African Research Ethics Committee Review of Standards of Prevention in HIV Vaccine Trial Protocols.
J Empir Res Hum Res Ethics. 2018 Jul;13(3):239-246. doi: 10.1177/1556264618763422. Epub 2018 Apr 9.
7
UNAIDS to publish HIV-vaccine-trial ethics guidance.
Lancet. 1999 Sep 11;354(9182):923. doi: 10.1016/S0140-6736(99)00162-2.
8
Ethical considerations in determining standard of prevention packages for HIV prevention trials: examining PrEP.
Dev World Bioeth. 2013 Aug;13(2):87-94. doi: 10.1111/dewb.12032. Epub 2013 May 31.
9
Some recent developments in the international guidelines on the ethics of research involving human subjects.
Ann N Y Acad Sci. 2000 Nov;918:170-8. doi: 10.1111/j.1749-6632.2000.tb05486.x.
10
Ethical issues in cluster randomized trials conducted in low- and middle-income countries: an analysis of two case studies.
Trials. 2020 Apr 16;21(Suppl 1):314. doi: 10.1186/s13063-020-04269-3.
引用本文的文献
1
Promising results of HIV prevention trials highlight the benefits of collaboration in global health: The perspective of the Forum HIV Recency Assay Working Group.
PLOS Glob Public Health. 2024 Oct 24;4(10):e0003878. doi: 10.1371/journal.pgph.0003878. eCollection 2024.
2
Partner protections in HIV cure-related trials involving analytical treatment interruption: Updated toolkit to mitigate HIV transmission risk.
J Virus Erad. 2024 Sep 11;10(3):100386. doi: 10.1016/j.jve.2024.100386. eCollection 2024 Sep.
3
A partner protection package for HIV cure-related trials involving analytical treatment interruptions.
Lancet Infect Dis. 2023 Oct;23(10):e418-e430. doi: 10.1016/S1473-3099(23)00267-0. Epub 2023 Jun 6.
4
Shifts in UNAIDS ethics guidance and implications for ethics review of preventive HIV vaccine trials.
J Int AIDS Soc. 2021 Nov;24 Suppl 7(Suppl 7):e25796. doi: 10.1002/jia2.25796.
5
Ethical issues in establishing the efficacy and safety of long-acting injectable pre-exposure prophylaxis for HIV prevention: the HPTN 083 trial.
Lancet HIV. 2021 Nov;8(11):e723-e728. doi: 10.1016/S2352-3018(21)00153-3. Epub 2021 Aug 26.
6
Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research.
HIV Res Clin Pract. 2021 Feb;22(1):14-30. doi: 10.1080/25787489.2021.1902116. Epub 2021 Mar 24.
7
The acceptability and feasibility of a pilot study examining the impact of a mobile technology-based intervention informed by behavioral economics to improve HIV knowledge and testing frequency among Latinx sexual minority men and transgender women.
BMC Public Health. 2021 Feb 12;21(1):341. doi: 10.1186/s12889-021-10335-5.
8
HIV prevention research and COVID-19: putting ethics guidance to the test.
BMC Med Ethics. 2021 Jan 25;22(1):6. doi: 10.1186/s12910-021-00575-w.
本文引用的文献
1
Collateral benefits: how the practical application of Good Participatory Practice can strengthen HIV research in sub-Saharan Africa.
J Int AIDS Soc. 2018 Oct;21 Suppl 7(Suppl Suppl 7):e25175. doi: 10.1002/jia2.25175.
2
It is not just about "the trial": the critical role of effective engagement and participatory practices for moving the HIV research field forward.
J Int AIDS Soc. 2018 Oct;21 Suppl 7(Suppl Suppl 7):e25179. doi: 10.1002/jia2.25179.
3
Embracing Transparency Through Data Sharing.
Int J Toxicol. 2018 Nov/Dec;37(6):466-471. doi: 10.1177/1091581818803880. Epub 2018 Oct 3.
4
Ethical considerations in global HIV phylogenetic research.
Lancet HIV. 2018 Nov;5(11):e656-e666. doi: 10.1016/S2352-3018(18)30134-6. Epub 2018 Aug 30.
5
HIV Preexposure Prophylaxis: A Review.
JAMA. 2018 Mar 27;319(12):1261-1268. doi: 10.1001/jama.2018.1917.
6
Implementing post-trial access plans for HIV prevention research.
J Med Ethics. 2018 May;44(5):354-358. doi: 10.1136/medethics-2017-104637. Epub 2018 Feb 27.
7
The Social Value of Knowledge and the Responsiveness Requirement for International Research.
Bioethics. 2017 Feb;31(2):97-104. doi: 10.1111/bioe.12316.
8
Antiretroviral Therapy for the Prevention of HIV-1 Transmission.
N Engl J Med. 2016 Sep 1;375(9):830-9. doi: 10.1056/NEJMoa1600693. Epub 2016 Jul 18.
9
Improving the transparency of prognosis research: the role of reporting, data sharing, registration, and protocols.
PLoS Med. 2014 Jul 8;11(7):e1001671. doi: 10.1371/journal.pmed.1001671. eCollection 2014 Jul.
10
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.
JAMA. 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053.
Zotero 插件